News & Updates

Show Multimedia Only
Telecarers improve treatment, compliance in older hip fracture patients

Telecarers improve treatment, compliance in older hip fracture patients

24 Apr 2023
Ventricular tachycardia may predict death in non-ischaemic cardiomyopathy patients

Ventricular tachycardia may predict death in non-ischaemic cardiomyopathy patients

24 Apr 2023 byAudrey Abella

Ventricular tachycardia predicts all-cause death and non-sudden cardiovascular death (NSCVD) in patients with non-ischaemic cardiomyopathy, a study suggests.

Ventricular tachycardia may predict death in non-ischaemic cardiomyopathy patients

24 Apr 2023
Psilocybin shows therapeutic potential for depression

Psilocybin shows therapeutic potential for depression

24 Apr 2023

For cancer patients with depression, treatment with a single dose of psilocybin appears to yield rapid and meaningful improvements in depressive symptoms, as shown in a phase II study.

Psilocybin shows therapeutic potential for depression

24 Apr 2023
Severe COVID patients 16 times more likely to experience V-tach

Severe COVID patients 16 times more likely to experience V-tach

24 Apr 2023 byElvira Manzano

Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia (V-tach) within 6 months following discharge compared with matched controls without severe infection in a Swedish case-control study presented at EHRA 2023.

Severe COVID patients 16 times more likely to experience V-tach

24 Apr 2023
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection

Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection

23 Apr 2023

Ten-day treatment with vonoprazan 20 mg twice/day plus amoxicillin 750 mg four times/day (VHA-dual) as a first-line therapy for Helicobacter pylori infection results in satisfactory eradication rate of >90 percent, fewer adverse events (AEs), and similar adherence when compared with bismuth quadruple therapy (B-quadruple), results of a study have shown.

Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection

23 Apr 2023